StonvexLoading…
StonvexStonvexStonvexCore line items from EPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $561.22M | $449.61M | $359.60M | $286.51M |
Operating Income | $359.92M | $278.19M | $242.75M | $175.42M |
Net Income | $253.01M | $203.00M | $190.71M | $134.13M |
EPS (Diluted) | $1.28 | $1.15 | $1.24 | $0.99 |
Total Assets | $6.86B | $5.80B | $4.77B | $4.00B |
Total Liabilities | $2.66B | $2.23B | $1.78B | $1.50B |
Cash & Equivalents | $60.18M | $40.71M | $39.81M | $62.34M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 209.70M | 187.54M | 164.64M | 142.38M |